MUTAH University

About Me

  • 00962 799569978
  • 009620 1234567
  • Al Karak - Mutah

" An individual with a strong and passionate interest in pharmacology with an array of related qualifications and professional experience also, a strong experience on mass spectrometry and a familiarity with the bioanalytical and molecular biology and pharmacology techniques.

I am currently working as an Assistant Professor and researcher of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Mutah University, Jordan. I have been teaching several Pharmacological and Therapeutics courses and pursuing research in the field of Cancer pharmacology since 2011. I have been awarded PhD from Institute of Cancer Therapeutics, University of Bradford, UK. Also, I have been awarded Clinical Pharmacy Diploma form Faculty of Pharmacy, Ain shams University Egypt, and I have been awarded my bachelor of pharmacy form Misr International University, Egypt.

My research work mainly focuses on Tumor-targeted Therapeutics for treatment of cancer cells with limited toxicities to normal cells.


Research Interest

The research interest is the molecular-based therapeutics targeting to enzymes-overexpressed in tumour leading to limited toxicities to normal tissues with high toxicity to tumour.

Published Research

Anticancer effect of different extracts of Cynanchum acutum L. seeds on cancer cell lines Journal : Pharmacognosy Magazine , Volume : 15 (64), 261Publisher : Medknow Publications , 2019
Cytotoxic Activity of Methanol Extract of Cynanchum acutum L. Seeds on Human Cancer Cell Lines Journal : Latin American Journal of Pharmacy , Volume : 37;(10)1997-2003Publisher : Latin American Journal of Pharmacy , 2018
Anti-Tumour Effect of two Persicaria Species Seeds on Colon and Prostate Cancers Journal : Biomedical and Pharmacology Journal , Volume : 11(2),635-644Publisher : Oriental Scientific Publishing Company , 2018
Glypican-3 expression in primary and metastatic neuroblastoma Journal : Jordan Journal of Biological Sciences , Volume : 9(4); 261-267Publisher : Hashemite University , 2016/12/1
Expression of Chemokine Receptor CXCR4 in Primary and Metastatic Neuroblastoma Expression of CXCR4 in Neuroblastoma Journal : Biomedical and Pharmacology Journal , Volume : 9 (2); 425-431Publisher : Oriental Scientific Pub. Co. ,
Screening of Glypican- 3 Expression in Human Normal Versus Benign and Malignant Tissues: A Comparative Study Glypican- 3 Expression in Cancers Journal : Biosciences Biotechnology Research Asia , Volume : 13 (2); 687-692Publisher : Oriental Scientific Pub. Co. , 2016/6/25
Comparative study of two Lotus species: Phytochemistry, cytotoxicity and antioxidant capacity Journal : Journal of Pharmacy & Pharmacognosy Research , Volume : 8(6);537-548Publisher : Asociacion Academica de Ciencias Farmaceuticas de Antofagasta (ASOCIFA) , 2020
Phytochemical and anti-cancer properties of Euphorbia hierosolymitana Boiss. crude extracts Journal : Journal of Pharmacy & Pharmacognosy Research , Volume : 9; 13–23Publisher : Journal of Pharmacy & Pharmacognosy Research , 2021
Profiling of CYP4Z1 and CYP1B1 expression in bladder cancers Journal : Scientific Reports , Volume : 11 (1), 1-8Publisher : Nature Publishing Group , 2021
Glypican-1 Overexpression in Different Types of Breast Cancers Journal : OncoTargets and Therapy , Volume : 2021:14 Pages 4309—4318Publisher : Dovepress , 2021


Pharmacology I
Third Year
Pharmacology II
Third Year
Pharmacology III
Fourth Year
Therapeutics I
Fourth Year
Therapeutics II
First Year
Clinical Cases
Fourth Year
Third Year
Pharmaceutical Technology
Third Year

News And Announcements

News Number 2
  • 25/02/2019
News Number 1
  • 07/02/2018
News Number3
  • 23/10/2012

Office Hours & More...